Federal Register / Vol. 65, No. 100 / Tuesday, May 23, 2000 / Notices 33337

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meetings.

The meetings will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Center for

Research Resources Special Emphasis Panel,

Comparative Medicine.

Date: June 8, 2000.

Time: 1 p.m. to 2 p.m.

Agenda: To review and evaluate grant

applications.

Place: Office of Review, National Center for

Research Resources, 6705 Rockledge Drive,

Bethesda, MD 20892 (Telephone Conference

Call).

Contact Person: Camille M. King, PhD.,

Scientific Review Administrator, Office of

Review, National Center for Research

Resources, National Institutes of Health, One

Rockledge Centre, MSC 7965, 6705

Rockledge Drive, Suite 6018, Bethesda, MD

20892–7965, 301–435–0815.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: National Center for

Research Resources Special Emphasis Panel,

Comparative Medicine.

Date: June 13, 2000.

Time: 1 p.m. to 2 p.m.

Agenda: To review and evaluate grant

applications.

Place: Office of Review, National Center for

Research Resources, 6705 Rockledge Drive,

Bethesda, MD 20892 (Telephone Conference

Call).

Contact Person: Camille M. King, PhD,

Scientific Review Administrator, Office of

Review, National Center for Research

Resources, National Institutes of Health, One

Rockledge Centre, MSC 7965, 6705

Rockledge Drive, Suite 6018, Bethesda, MD

20892–7965, 301–435–0815.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: National Center for

Research Resources Special Emphasis Panel,

General Clinical Research Centers.

Date: June 13, 2000.

Time: 7 p.m. to 11 p.m.

Agenda: To review and evaluate grant

applications.

Place: Doubletree Hotel, 1750 Rockville

Pike, Rockville, MD 20852.

Contact Person: John L. Meyer, PhD,

Deputy Director, Office of Review, National

Center for Research Resources, National

Institutes of Health, 6705 Rockledge Drive,

MSC 7965, One Rockledge Centre, Suite

6018, Bethesda, MD 20892–7965, 301–435–

0806.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.306, Comparative Medicine,

93.306; 93.333, Clinical Research, 93.333;

93.371, Biomedical Technology; 93.389,

Research Infrastructure, National Institutes of

Health, HHS)

Dated: May 16, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–12902 Filed 5–22–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Heart, Lung, and Blood

Institute; Amended Notice of Meeting

Notice is hereby given of a change in

the meeting of the National Heart, Lung,

and Blood Institute Special emphasis

Panel, June 7, 2000, 7 PM to June 8,

2000, 3 PM, Columbia Sheraton, 10207

Wincopin Circle, Columbia, MD, 21044

which was published in the Federal

Register on April 2, 2000, 65 FR 24491–

24492.

The name of the meeting will be

changed to Hematopoietic Stem Cell

Biology RFA. The meeting is closed to

the public.

Dated: May 12, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–12905 Filed 5–22–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Heart, Lung, and Blood

Institute; Cancellation of Meeting

Notice is hereby given of the

cancellation of the National Heart, Lung,

and Blood Institute Special Emphasis

Panel, May 17, 2000, 2:30 p.m. to May

17, 2000, 3:30 p.m., NIH, Rockledge II,

Bethesda, MD, 20892 which was

published in the Federal Register on

April 26, 2000, 65 FR 24491–24492.

The meeting is cancelled due to the

fact that a review meeting is no longer

required.

Dated: May 12, 2000.

LeVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–12906 Filed 5–22–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute on Drug Abuse;

Notice of Closed Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meetings.

The meetings will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute on

Drug Abuse Initial Review Group,

Medication Development Research

Subcommittee.

Date: June 28, 2000.

Time: 8 a.m. to 2 p.m.

Agenda: To review and evaluate grant

applications.

Place: Arlington Hyatt, 1325 Wilson

Boulevard, Arlington, VA 22209.

Contact Person: Khursheed Asghar, PhD,

Chief, Basic Sciences Review Branch, Office

of Extramural Affairs, National Institute on

Drug Abuse, National Institutes of Health,

6001 Executive Boulevard, Room 3158, Msc

9547, Bethesda, MD 20892–9547, (301) 443–

2620.

Name of Committee: National Institute on

Drug Abuse Special Emphasis Panel,

Minority Institutions’ Drug Abuse Research

Development Program.

Date: June 28, 2000.

Time: 3 p.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: Hyatt Arlington, 1325 Wilson

Boulevard, Arlington, VA 22209.

Contact Person: Khursheed Asghar, PhD,

Chief, Basic Sciences Review Branch, Office

of Extramural Affairs, National Institute on

Drug Abuse, National Institutes of Health,

6001 Executive Boulevard, Room 3158, Msc

9547, Bethesda, MD 29089–2954, (301) 443–

2620.

Name of Committee: National Institute on

Drug Abuse Initial Review Group, Health

Services Research Subcommittee.

Date: June 29–30, 2000.